[go: up one dir, main page]

NO20015510L - Medikament for lokal påföring - Google Patents

Medikament for lokal påföring

Info

Publication number
NO20015510L
NO20015510L NO20015510A NO20015510A NO20015510L NO 20015510 L NO20015510 L NO 20015510L NO 20015510 A NO20015510 A NO 20015510A NO 20015510 A NO20015510 A NO 20015510A NO 20015510 L NO20015510 L NO 20015510L
Authority
NO
Norway
Prior art keywords
medication
local application
local
application
Prior art date
Application number
NO20015510A
Other languages
English (en)
Other versions
NO329232B1 (no
NO20015510D0 (no
Inventor
Johann Eibl
Original Assignee
Bio & Bio Licensing Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio & Bio Licensing Sa filed Critical Bio & Bio Licensing Sa
Publication of NO20015510L publication Critical patent/NO20015510L/no
Publication of NO20015510D0 publication Critical patent/NO20015510D0/no
Publication of NO329232B1 publication Critical patent/NO329232B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/196—Thrombopoietin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20015510A 1999-05-19 2001-11-12 Medikament for lokal paforing og framgangsmate for framstilling av en fibrinogenholdig losning NO329232B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0089599A AT500670A1 (de) 1999-05-19 1999-05-19 Arzneimittel zur lokalen anwendung
PCT/AT2000/000141 WO2000071153A2 (de) 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält

Publications (3)

Publication Number Publication Date
NO20015510L true NO20015510L (no) 2001-11-12
NO20015510D0 NO20015510D0 (no) 2001-11-12
NO329232B1 NO329232B1 (no) 2010-09-20

Family

ID=3502302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015510A NO329232B1 (no) 1999-05-19 2001-11-12 Medikament for lokal paforing og framgangsmate for framstilling av en fibrinogenholdig losning

Country Status (14)

Country Link
US (1) US20020114796A1 (no)
EP (3) EP1275397B1 (no)
JP (1) JP2003500364A (no)
AT (1) AT500670A1 (no)
AU (1) AU5198600A (no)
CA (1) CA2372929C (no)
DE (1) DE50005999D1 (no)
DK (2) DK1275397T3 (no)
ES (2) ES2218167T3 (no)
HU (1) HU226016B1 (no)
MX (1) MXPA01011859A (no)
NO (1) NO329232B1 (no)
SK (1) SK16332001A3 (no)
WO (1) WO2000071153A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US7326412B2 (en) * 2000-10-13 2008-02-05 Baxter International Inc. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
WO2002030446A2 (en) * 2000-10-13 2002-04-18 Baxter International Inc. Reduction or prevention of post-surgical adhesion formation with fibrinogen
CA2435248A1 (en) * 2001-01-18 2002-07-25 Johann Eibl Drug composition for the promotion of tissue regeneration
US8529956B2 (en) 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US8293530B2 (en) 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
ATE554394T1 (de) 2005-07-13 2012-05-15 Crossbeta Biosciences Bv Cross-beta-struktur-bindende verbindungen
US20080249606A1 (en) * 2005-07-13 2008-10-09 Martijn Frans Ben Gerard Gebbink Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
EP2058000A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Immunogenic compositions capable of activating T cells
WO2009155626A2 (de) * 2008-06-23 2009-12-30 Bio-Products & Bio-Engineering Ag Lagerstabiles, funktionell intaktes fibrinogen
WO2011023843A2 (es) * 2009-08-25 2011-03-03 Servicio Andaluz De Salud Elaboración de tejidos artificiales mediante ingeniería tisular utilizando biomateriales de fibrina y agarosa
JP6875619B2 (ja) * 2015-02-26 2021-05-26 株式会社細胞応用技術研究所 多血小板血漿の保存方法
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
EP0534178B1 (en) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
US5514579A (en) * 1991-12-31 1996-05-07 Zymogenetics, Inc. Human transglutaminases
US5254536A (en) * 1992-01-10 1993-10-19 The Du Pont Merck Pharmaceutical Company Therapeutic utility of plasminogen activator inhibitor-1 to control bleeding
EP0598133B1 (en) * 1992-04-21 2000-03-29 Ajinomoto Co., Inc. Remedy for wound
JPH0654897A (ja) * 1992-08-08 1994-03-01 Chemo Sero Therapeut Res Inst フィブリノーゲン含有製剤
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
JP3620055B2 (ja) * 1994-01-31 2005-02-16 味の素株式会社 創傷治療剤
AT406120B (de) * 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
AT407117B (de) * 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm

Also Published As

Publication number Publication date
CA2372929C (en) 2011-11-15
WO2000071153A3 (de) 2001-04-26
HU226016B1 (en) 2008-02-28
HUP0200856A3 (en) 2004-11-29
JP2003500364A (ja) 2003-01-07
MXPA01011859A (es) 2003-09-04
EP1275397A3 (de) 2003-07-02
EP1275397A2 (de) 2003-01-15
ES2218167T3 (es) 2004-11-16
HUP0200856A2 (hu) 2002-07-29
DK1275397T3 (da) 2014-09-22
WO2000071153A2 (de) 2000-11-30
EP1275397B1 (de) 2014-08-06
EP1183043A2 (de) 2002-03-06
NO329232B1 (no) 2010-09-20
AU5198600A (en) 2000-12-12
AT500670A1 (de) 2006-02-15
SK16332001A3 (sk) 2002-05-09
EP1632246A2 (de) 2006-03-08
CA2372929A1 (en) 2000-11-30
EP1183043B1 (de) 2004-04-07
DK1183043T3 (da) 2004-08-09
NO20015510D0 (no) 2001-11-12
DE50005999D1 (de) 2004-05-13
ES2499090T3 (es) 2014-09-26
US20020114796A1 (en) 2002-08-22
EP1632246A3 (de) 2009-03-11

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
DE60044873D1 (de) Orientierte biopolymermembrane
DE60037203D1 (de) Medikamentenspender
DE60011853D1 (de) Injektionsspritze
FI991485L (fi) Uusi farmaseuttinen koostumus
DE122007000064I1 (de) Erythropoietinkonjugate
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
NO20015510D0 (no) Medikament for lokal påföring
IS2139B (is) Kvetíapínagnir
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
NO990431D0 (no) Golfk°llehode
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20022606L (no) Farmasöytiske kombinasjoner
NO20014926L (no) Farmasöytiske forbindelser
NO20020773D0 (no) Borkronekobling
DE10085008T1 (de) Oberflächenbehandlungsdüse
FI4488U1 (fi) Farmaseuttinen koostumus
IS6163A (is) Lyfjakomplex
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
ATE440824T1 (de) Nitro-sulfobenzamide
ATE269311T1 (de) Benzoylpyridazine
DE10082008D2 (de) Ausbeulgerät
ATA107599A (de) Heizwasserbereiter

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BIO & BIO LICENSING SA, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BIO PRODUCTS & BIO-ENGINEERING AKTIENGESELLS, AT

MM1K Lapsed by not paying the annual fees